PAR
Click for more information
0.00% 27.0¢ paradigm biopharmaceuticals limited..

AGM Meeting

  1. m931392
    79 Posts.
    lightbulb Created with Sketch. 6
    clock Created with Sketch.
    29/11/23
    11:41
    Post #: 71165727
    Paradigm claims that iPPS is a 1B market for OA and that the drug is "statistically significant" and DMOAD. However, there doesn't appear to be any interest in partnering for OA...how could that be?
    PAR Price at posting: 39.0¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply
 

Featured News

TEA Newest ASX entrant, Tasmea Ltd, up 12.5% on maiden debut
right-arrow Created with Sketch.
HLX Gold anomalies across several kilometres impress Helix in NSW
right-arrow Created with Sketch.
BPH BPH Energy wraps up Q1 with $6.6M in cash but Canberra still stalling shareholders on PEP-11
right-arrow Created with Sketch.
RNT Rent.com.au hits $250M in RentPay payments as housing crisis rolls on
right-arrow Created with Sketch.
NEWS Quarterly Wrap: Frontier Energy & Haranga Resources
right-arrow Created with Sketch.
LU7 Lithium Universe ends the quarter on the charge for Quebec Refinery development
right-arrow Created with Sketch.

Top Stories

watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
27.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $94.44M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 594 29.0¢
 

Sellers (Offers)

Price($) Vol. No.
27.0¢ 200 1
View Market Depth
Last trade - 09.30am 01/05/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.